Three dimensional model of severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain and molecular design of severe acute respiratory syndrome coronavirus helicase inhibitors

被引:11
|
作者
Hoffmann, Marcin
Eitner, Krystian
von Grotthuss, Marcin
Rychlewski, Leszek
Banachowicz, Ewa
Grabarkiewicz, Tomasz
Szkoda, Tomasz
Kolinski, Andrzej
机构
[1] BioInfoBank Inst, PL-60744 Poznan, Poland
[2] Adam Mickiewicz Univ, Fac Chem, Quantum Chem Grp, PL-60780 Poznan, Poland
[3] Adam Mickiewicz Univ, Dept Phys, Bioinformat Unit, PL-61614 Poznan, Poland
[4] Natl Inst Hyg, Dept Virol, Resp Virus Lab, PL-00791 Warsaw, Poland
[5] Warsaw Univ, Fac Chem, PL-02093 Warsaw, Poland
关键词
SARS; inhibitors; drug design; computational chemistry; bioinformatics;
D O I
10.1007/s10822-006-9057-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The modeling of the severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain was performed using the protein structure prediction Meta Server and the 3D Jury method for model selection, which resulted in the identification of 1JPR, 1UAA and 1W36 PDB structures as suitable templates for creating a full atom 3D model. This model was further utilized to design small molecules that are expected to block an ATPase catalytic pocket thus inhibit the enzymatic activity. Binding sites for various functional groups were identified in a series of molecular dynamics calculation. Their positions in the catalytic pocket were used as constraints in the Cambridge structural database search for molecules having the pharmacophores that interacted most strongly with the enzyme in a desired position. The subsequent MD simulations followed by calculations of binding energies of the designed molecules were compared to ATP identifying the most successful candidates, for likely inhibitors-molecules possessing two phosphonic acid moieties at distal ends of the molecule.
引用
收藏
页码:305 / 319
页数:15
相关论文
共 50 条
  • [31] Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome
    Guan, Y
    Peiris, JSM
    Zheng, B
    Poon, LLM
    Chan, KH
    Zeng, FY
    Chan, CWM
    Chan, MN
    Chen, JD
    Chow, KYC
    Hon, CC
    Hui, KH
    Li, J
    Li, VYY
    Wang, Y
    Leung, SW
    Yuen, KY
    Leung, FC
    LANCET, 2004, 363 (9403): : 99 - 104
  • [32] Respiratory management in severe acute respiratory syndrome coronavirus 2 infection
    Price, Susanna
    Singh, Suveer
    Ledot, Stephane
    Bianchi, Paolo
    Hind, Matthew
    Tavazzi, Guido
    Vranckx, Pascal
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2020, 9 (03) : 229 - 238
  • [33] Respiratory sampling for severe acute respiratory syndrome coronavirus 2: An Overview
    See, Anna
    Toh, Song Tar
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2020, 42 (07): : 1652 - 1656
  • [34] Hamsters as a Model of Severe Acute Respiratory Syndrome Coronavirus-2
    Braxton, Alicia M.
    Creisher, Patrick S.
    Ruiz-Bedoya, Camilo A.
    Mulka, Katie R.
    Dhakal, Santosh
    Ordonez, Alvaro A.
    Beck, Sarah E.
    Jain, Sanjay K.
    Villano, Jason S.
    COMPARATIVE MEDICINE, 2021, 71 (05) : 1 - 13
  • [35] Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Entry That Act by Three Distinct Mechanisms
    Adedeji, Adeyemi O.
    Severson, William
    Jonsson, Colleen
    Singh, Kamalendra
    Weiss, Susan R.
    Sarafianos, Stefan G.
    JOURNAL OF VIROLOGY, 2013, 87 (14) : 8017 - 8028
  • [36] A design of computational stochastic framework for the mathematical severe acute respiratory syndrome coronavirus model
    Asghar, Atifa
    Hassan, Mohsan
    Sabir, Zulqurnain
    Bhat, Shahid Ahmad
    Alhazmi, Sharifah E.
    BIOMEDICAL SIGNAL PROCESSING AND CONTROL, 2025, 100
  • [37] Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
    Simmons, G
    Gosalia, DN
    Rennekamp, AJ
    Reeves, JD
    Diamond, SL
    Bates, P
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (33) : 11876 - 11881
  • [38] Tafenoquine and its derivatives as inhibitors for the severe acute respiratory syndrome coronavirus 2
    Chen, Yeh
    Yang, Wen-Hao
    Chen, Hsiao-Fan
    Huang, Li-Min
    Gao, Jing-Yan
    Lin, Cheng-Wen
    Wang, Yu-Chuan
    Yang, Chia-Shin
    Liu, Yi-Liang
    Hou, Mei-Hui
    Tsai, Chia-Ling
    Chou, Yi-Zhen
    Huang, Bao-Yue
    Hung, Chian-Fang
    Hung, Yu-Lin
    Wang, Wei-Jan
    Su, Wen-Chi
    Kumar, Vathan
    Wu, Yu-Chieh
    Chao, Shih-Wei
    Chang, Chih-Shiang
    Chen, Jin-Shing
    Chiang, Yu-Ping
    Cho, Der-Yang
    Jeng, Long-Bin
    Tsai, Chang-Hai
    Hung, Mien-Chie
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (03)
  • [39] The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5′ to 3′ viral helicases
    Tanner, JA
    Watt, RM
    Chai, YB
    Lu, LY
    Lin, MC
    Peiris, JSM
    Poon, LLM
    Kung, HF
    Huang, JD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (41) : 39578 - 39582
  • [40] Zoonotic coronavirus epidemics Severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019
    Fung, Monica
    Otani, Iris
    Pham, Michele
    Babik, Jennifer
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (04) : 321 - 337